Dr Nikhil Mayor, Fran Rawlins, Dr Alexander Light and Dr Phil Mcnamee with a TRANSFORM leaflet, and children playing the team's hook-a-duck game, designed to illustrate how a screening trial for prostate cancer could work.

[4/8]
🦆The TRANSFORM team @nikhilmayor.bsky.social, Fran Rawlins, @ajwlight.bsky.social @philmcnamee.bsky.social @ip-london.bsky.social helped supporters of all ages understand how we’re working to find the best way to screen men for #ProstateCancer.

5yr outcomes following Rezum for >80mL prostates presented by @ajwlight.bsky.social (on behalf of Yan Leung) #AUA25 🇺🇸

Take home message - 3 of 4 patients were free of retreatment by 5 years

@ajwlight.bsky.social presents preliminary validation data on the #TARGET scoring system - good specificity and NPV for detecting GG2+ in-field disease

Watch this space for our definitive multi centre validation study! #AUA25 🇺🇸

Update of #IP7PACIFIC presented by @ajwlight.bsky.social at #AUA25 🇺🇸

This will be the first trial to provide definitive evidence comparing bpMRI vs mpMRI, alongside fusion vs cognitive biopsy

>1200 patients recruited across the UK - watch this space

Is bpMRI non-inferior to mpMRI? Is image-fusion biopsy superior to cognitive biopsy?

@nikhilmayor.bsky.social gives an update on the #IP7PACIFIC trial with >1,000 patients recruited so far #EAU25 🇪🇸

Next is Dr Archana Gopalakrishnan discussing the #IP9ATLAS trial

For active surveillance, is regular MRI superior to standard care for detecting progression? Recruitment is open and the trial will randomise 1263 patients in 30 centres. Watch this space! #EAU25 🇪🇸

Next up: PhD Fellow @ajwlight.bsky.social presents an update from the multicentre blinded #IP8FLUORESCE study evaluating #ConfocalMicroscopy for margin status in #RadicalProstatectomy - recruitment complete and results out on Monday 24/03 at #EAU25 🇪🇸

It’s a big first day at #EAU25 for our clinical trials & PhD fellows! 🚀

Come along at 15:15 to ‘On the horizon: Ongoing trials in urology’ in Green Area Retiro

@nikhilmayor.bsky.social presenting #IP7PACIFIC
@ajwlight.bsky.social presenting #IP8FLUORESCE
Archana Gopalakrishnan presenting #IP9ATLAS

👆👍🙏
@ivyradoncmd.bsky.social @meghatron94.bsky.social @londonprostate1.bsky.social @lambalastair.bsky.social @daviesbj.bsky.social @yawnyame.bsky.social @danlinmd.bsky.social @loebstacy.bsky.social @keithkow.bsky.social @mariajribal.bsky.social @ajwlight.bsky.social @wandering-gu.bsky.social

Exciting times on a new platform! Looking forward to connecting and collaborating with everyone and seeing the prostate cancer community thrive

The protocol paper for the IP8-FLUORESCE trial is now published #openaccess in @bjuijournal.bsky.social ! Excellent work led by Nikhil Mayor and Matt Winkler

Keep tuned for the results!

Read for free: https://buff.ly/48ZquK5

It was a record meeting for Imperial Prostate at #BAUSOncology 2024 with presentations on prostate cancer screening, early detection, molecular imaging and discussion of many of our ongoing/upcoming trials from our fellows, lecturers, and consultants #ATLAS #AVIDITY #FLUORESCE #PACIFIC #TRANSFORM